Semler Scientific (SMLR) Competitors $59.27 +12.93 (+27.90%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMLR vs. AORT, ESTA, PLSE, BLFS, BVS, CBLL, EYE, FNA, LQDA, and AVNSShould you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Artivion (AORT), Establishment Labs (ESTA), Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Bioventus (BVS), CeriBell (CBLL), National Vision (EYE), Paragon 28 (FNA), Liquidia (LQDA), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry. Semler Scientific vs. Artivion Establishment Labs Pulse Biosciences BioLife Solutions Bioventus CeriBell National Vision Paragon 28 Liquidia Avanos Medical Artivion (NYSE:AORT) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, community ranking, media sentiment, valuation and institutional ownership. Which has more risk & volatility, AORT or SMLR? Artivion has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500. Do analysts prefer AORT or SMLR? Artivion presently has a consensus target price of $31.00, suggesting a potential upside of 14.14%. Given Artivion's higher probable upside, equities analysts clearly believe Artivion is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Artivion 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Which has stronger earnings and valuation, AORT or SMLR? Semler Scientific has lower revenue, but higher earnings than Artivion. Artivion is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArtivion$384.90M2.96-$30.69M-$0.02-1,358.00Semler Scientific$68.18M6.32$20.58M$2.0528.91 Does the media prefer AORT or SMLR? In the previous week, Semler Scientific had 2 more articles in the media than Artivion. MarketBeat recorded 3 mentions for Semler Scientific and 1 mentions for Artivion. Artivion's average media sentiment score of 1.76 beat Semler Scientific's score of -0.11 indicating that Artivion is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Artivion 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Semler Scientific 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in AORT or SMLR? 86.4% of Artivion shares are held by institutional investors. Comparatively, 49.4% of Semler Scientific shares are held by institutional investors. 8.1% of Artivion shares are held by company insiders. Comparatively, 30.2% of Semler Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community believe in AORT or SMLR? Artivion received 21 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 78.57% of users gave Artivion an outperform vote while only 50.00% of users gave Semler Scientific an outperform vote. CompanyUnderperformOutperformArtivionOutperform Votes2278.57% Underperform Votes621.43% Semler ScientificOutperform Votes150.00% Underperform Votes150.00% Is AORT or SMLR more profitable? Semler Scientific has a net margin of 27.00% compared to Artivion's net margin of -0.22%. Semler Scientific's return on equity of 20.31% beat Artivion's return on equity.Company Net Margins Return on Equity Return on Assets Artivion-0.22% 5.15% 1.91% Semler Scientific 27.00%20.31%18.78% SummarySemler Scientific beats Artivion on 11 of the 19 factors compared between the two stocks. Ad Wyatt Investment ResearchMy #1 Pre IPO Trade for 2025 – NAME and TICKEROne tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...The Next SpaceX Pre-IPO Get Semler Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMLR vs. The Competition Export to ExcelMetricSemler ScientificElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$336.72M$3.44B$5.05B$8.87BDividend YieldN/A1.68%4.97%4.06%P/E Ratio28.9112.9697.3414.18Price / Sales6.3292.811,218.4289.42Price / Cash15.0447.1633.5132.79Price / Book5.043.935.805.12Net Income$20.58M$92.21M$119.07M$225.99M7 Day Performance30.84%-3.40%-1.83%-1.32%1 Month Performance119.52%6.80%-3.64%0.60%1 Year Performance60.49%17.06%31.62%26.23% Semler Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMLRSemler Scientific1.0709 of 5 stars$59.27+27.9%N/A+60.6%$336.72M$68.18M28.9192Gap UpHigh Trading VolumeAORTArtivion1.9659 of 5 stars$27.16+0.9%$31.00+14.1%+92.4%$1.13B$354M0.001,500Positive NewsESTAEstablishment Labs2.1311 of 5 stars$41.81+11.4%$60.60+44.9%+90.0%$1.05B$165.15M0.00960High Trading VolumePLSEPulse Biosciences1.5329 of 5 stars$16.14-5.3%N/A+157.8%$1.05B$700,000.000.00140Positive NewsBLFSBioLife Solutions0.8729 of 5 stars$25.01+11.5%$27.50+10.0%+86.5%$1.04B$143.27M0.00409Analyst ForecastInsider TradeAnalyst RevisionBVSBioventus2.7241 of 5 stars$11.41-1.6%$13.00+13.9%+195.6%$925.98M$555.06M-18.701,200Positive NewsCBLLCeriBellN/A$25.06-2.0%$31.20+24.5%N/A$897.65MN/A0.00N/AQuiet Period ExpirationAnalyst RevisionEYENational Vision3.0614 of 5 stars$11.34+0.5%$14.00+23.5%-42.1%$888.30M$2.13B0.0013,998Positive NewsFNAParagon 282.1549 of 5 stars$10.35-1.4%$15.60+50.7%-0.3%$879.06M$216.39M0.00343,000Analyst RevisionLQDALiquidia3.7407 of 5 stars$10.12-0.4%$24.00+137.2%+55.7%$859.91M$17.49M0.0050Analyst RevisionAVNSAvanos Medical3.9807 of 5 stars$17.87+0.4%N/A-16.6%$818.03M$673.30M52.563,771Positive News Related Companies and Tools Related Companies Artivion Alternatives Establishment Labs Alternatives Pulse Biosciences Alternatives BioLife Solutions Alternatives Bioventus Alternatives CeriBell Alternatives National Vision Alternatives Paragon 28 Alternatives Liquidia Alternatives Avanos Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMLR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Semler Scientific, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Semler Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
